Grünwald, V., Jacobasch, L., Wit, M. D., Banek, S., Niegisch, G., Zahn, M., Neisius, A., Marks, P., Müller, M., Weikersthal, L. V., Huebner, A., Augustin, M., Heyde, E. V. D., Thomas, C., Gilbert, N., Fehr, A., Stauder, H., Vehling-Kaiser, U., Eckert, R., Ivanyi, P. (2025). A phase III study testing the role of proactive coaching on patient reported outcome in advanced or metastatic renal cell carcinoma treated with sunitinib or a combination of axitinib + pembrolizumab or avelumab in first line therapy (PREPARE; AIO-NZK-0115/ass).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.523